According to published reports in the Globe and Mail, McKesson Corp. is looking to divest its Canadian drugstore chain, Rexall Pharmacy Group, seven years after the initial acquisition valued at approximately $3 billion (US$2.2 billion).
Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK.
Hoffmann-La Roche Limited (Roche Canada) is proud to announce a dynamic collaboration with McKesson Canada (McKesson) which has resulted in solutions that will optimize the patient journey and potentially shorten overall time to therapy.
BD (Becton, Dickinson and Company), a leading global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place on January 24-25, 2024 at Paris Expo, Porte de Versailles, in Paris.
Hy-Vee, Inc. and Soda Health launched a new Smart Benefits program that allows recipients to receive personalized health and wellness benefits at all Hy-Vee locations across the retailer’s eight-state region.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S.
Rite Aid Corp. announced that the U.S. Bankruptcy Court for the District of New Jersey has approved the sale of the company’s Elixir Solutions Business to MedImpact Healthcare Systems, Inc. (MedImpact), an independent pharmacy benefit solutions company.
According to published reports, Walgreens Boots Alliance (WBA) has agreed to pay Humana $360M in settlement for a lawsuit that alleged that the retail-pharmacy chain overcharged for prescription-drug reimbursements.
a great friend of NACDS — stand the
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Former Defense Secretary Donald Rumsfeld once observed that “there are known knowns. There are things we know we know. We also know there are known unknowns.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation.
ARLINGTON, Va. – A new television ad from NACDS urges Congress to enact bipartisan pharmacy benefit manager (PBM) reforms that it has advanced in this legislative session.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive.
